{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:49:08Z","timestamp":1766515748310},"reference-count":63,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2021,11,2]]},"DOI":"10.1080\/17512433.2021.1950531","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T08:59:20Z","timestamp":1625043560000},"page":"1345-1352","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Immunotherapy of High Risk Non-Muscle Invasive Bladder Cancer"],"prefix":"10.1080","volume":"14","author":[{"given":"Michael","family":"Ahdoot","sequence":"first","affiliation":[{"name":"Department of Surgery (Urology), Cedars-Sinai Medical Center, Los Angeles, CA, USA"},{"name":"Department of Surgery, Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Theodorescu","sequence":"additional","affiliation":[{"name":"Department of Surgery (Urology), Cedars-Sinai Medical Center, Los Angeles, CA, USA"},{"name":"Department of Surgery, Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA"},{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,7,10]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2005.07.062"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.08.016"},{"issue":"2","key":"cit0005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eururo.2015.05.050","volume":"69","author":"Sylvester RJ","year":"2016","journal-title":"Eur Urol"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.4657"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)52736-6"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-199707000-00017"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2005.12.031"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)58737-6"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.02.061"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64273-5"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1159\/000474914"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-018-0055-4"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2019.905"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.11.124"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1007\/BF01741551"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.09.026"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1007\/BF01534428"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000073852.24341.4a"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.4161\/onci.20640"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01734.x"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)65469-9"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67707-5"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2003.11.049"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.11.031"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1080\/13547500902818246"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.12.024"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2017.04.086"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-3016"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1038\/nri2326"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00561"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.7609"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2010.00923.x"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0316-z"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.03.055"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0084"},{"key":"cit0038","unstructured":"\u2022 Roche provides update on Tecentriq US indication in prior-platinum treated metastatic bladder cancer. [cited 2021 Mar 29]. Available from: https:\/\/www.roche.com\/media\/releases\/med-cor-2021-03-08.htm"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.5041"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.5022"},{"key":"cit0041","unstructured":"Merck Sharp & Dohme Corp. A phase 3, randomized, comparator-controlled clinical trial to study the efficacy and safety of pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in participants with high-risk non-muscle invasive bladder cancer (HR NMIBC) that is either persistent or recurrent following BCG induction or that is Na\u00efve to BCG treatment (KEYNOTE-676). clinicaltrials.gov; 2020 [cited 2021 Mar 9]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03711032"},{"issue":"13","key":"cit0042","volume":"79","author":"Alanee S","year":"2019","journal-title":"Cancer Res"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.6_suppl.510"},{"key":"cit0044","unstructured":"Research C for DE and. FDA approves pembrolizumab for BCG-unresponsive, high-risk non-muscle invasive bladder cancer. FDA. Published online 2020 Jan 8 [cited 2021 Mar 10]. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-pembrolizumab-bcg-unresponsive-high-risk-non-muscle-invasive-bladder-cancer"},{"key":"cit0045","author":"Pfail JL","year":"2020","journal-title":"World J Urol"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.7_suppl.406"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2013.57"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.42.25107"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1126\/science.1131078"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2009.00770.x"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000313"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30541-6"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00538"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30496-X"},{"key":"cit0055","unstructured":"Squibb B-M. A phase 3, open-label, randomized study of nivolumab combined with ipilimumab, or with standard of care chemotherapy, versus standard of care chemotherapy in participants with previously untreated unresectable or metastatic urothelial cancer. clinicaltrials.gov; 2021 [cited 2021 Mar 16]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03036098"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700488"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7701011"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2004.05.027"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700865"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2005.02.015"},{"issue":"1","key":"cit0061","volume":"32","author":"Lamm D","year":"2014","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000136446.37840.0a"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30540-4"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2021.1950531","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T18:31:25Z","timestamp":1635273085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2021.1950531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,10]]},"references-count":63,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11,2]]}},"alternative-id":["10.1080\/17512433.2021.1950531"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2021.1950531","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-04-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}